Total Payments
$54,994
2024 Payments
$734.64
Companies
40
Transactions
355
Medicare Patients
11,912
Medicare Billing
$1.1M
Payment Breakdown by Category
Royalty/License$46,257 (84.1%)
Food & Beverage$6,284 (11.4%)
Travel$2,348 (4.3%)
Education$104.75 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Royalty or License | $46,257 | 1 | 84.1% |
| Food and Beverage | $6,284 | 345 | 11.4% |
| Travel and Lodging | $2,348 | 7 | 4.3% |
| Education | $104.75 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $49,350 | 24 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $1,034 | 72 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $523.42 | 34 | $0 (2023) |
| Boston Scientific Corporation | $392.01 | 28 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $361.41 | 21 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $282.90 | 25 | $0 (2024) |
| Merck Sharp & Dohme LLC | $204.75 | 9 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $203.95 | 20 | $0 (2019) |
| Amgen Inc. | $197.78 | 11 | $0 (2024) |
| Cardiovascular Systems Inc. | $189.17 | 7 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $734.64 | 44 | Boston Scientific Corporation ($162.54) |
| 2023 | $684.04 | 31 | Merck Sharp & Dohme LLC ($111.82) |
| 2022 | $98.81 | 8 | Novartis Pharmaceuticals Corporation ($69.17) |
| 2021 | $495.41 | 29 | Novartis Pharmaceuticals Corporation ($89.87) |
| 2020 | $423.02 | 21 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($142.86) |
| 2019 | $1,138 | 79 | Novartis Pharmaceuticals Corporation ($281.85) |
| 2018 | $50,250 | 71 | Abbott Laboratories ($49,208) |
| 2017 | $1,170 | 72 | Novartis Pharmaceuticals Corporation ($215.64) |
All Payment Transactions
355 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | Xeris Pharmaceuticals, Inc. | KEVEYIS (Drug) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: Carbonic anhydrase inhibitor | ||||||
| 11/12/2024 | iRhythm Technologies, Inc. | Zio monitor (Device), ZIO XT Patch | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/07/2024 | Boston Scientific Corporation | AVVIGO Guidance System (Device) | Food and Beverage | In-kind items and services | $12.87 | General |
| Category: AVVIGO_IC | ||||||
| 10/23/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $21.38 | General |
| Category: Cardiovascular | ||||||
| 10/16/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/27/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $12.58 | General |
| Category: General - Atherectomy_PI | ||||||
| 09/11/2024 | Boston Scientific Corporation | AVVIGO Guidance System (Device) | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: AVVIGO_IC | ||||||
| 09/04/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $21.81 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/20/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $25.00 | General |
| 08/13/2024 | Boston Scientific Corporation | Ranger (Device) | Food and Beverage | In-kind items and services | $4.42 | General |
| Category: Ranger_PI | ||||||
| 08/08/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: Diabetes | ||||||
| 08/01/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 08/01/2024 | Boston Scientific Corporation | AVVIGO Guidance System (Device) | Food and Beverage | In-kind items and services | $12.11 | General |
| Category: AVVIGO_IC | ||||||
| 07/24/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/27/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/25/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $21.08 | General |
| Category: Cardiology | ||||||
| 06/25/2024 | Boston Scientific Corporation | AVVIGO Guidance System (Device) | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: AVVIGO_IC | ||||||
| 06/20/2024 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: VTE | ||||||
| 06/04/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 05/29/2024 | Boston Scientific Corporation | LATITUDE Communicator Power Supply (Device) | Food and Beverage | In-kind items and services | $10.60 | General |
| Category: LATITUDE_CRM | ||||||
| 05/22/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $16.00 | General |
| 05/16/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $28.09 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/09/2024 | Inari Medical, Inc. | CT THROMBECTOMY SYSTEM KIT (Device), FLOWTRIEVER CATHETER, S | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: VTE | ||||||
| 05/01/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/25/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: General - Vascular Intervention_PI | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 3,129 | 4,205 | $959,544 | $299,451 |
| 2022 | 24 | 2,756 | 3,985 | $692,457 | $244,070 |
| 2021 | 26 | 2,988 | 4,249 | $797,970 | $272,821 |
| 2020 | 28 | 3,039 | 4,264 | $855,425 | $270,185 |
Total Patients
11,912
Total Services
16,703
Medicare Billing
$1.1M
Procedure Codes
117
All Medicare Procedures & Services
117 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 503 | 734 | $150,470 | $63,445 | 42.2% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 172 | 172 | $176,580 | $53,326 | 30.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 381 | 397 | $173,092 | $50,563 | 29.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 158 | 383 | $54,003 | $23,539 | 43.6% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 64 | 64 | $44,672 | $13,118 | 29.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 84 | 96 | $37,875 | $12,937 | 34.2% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 164 | 166 | $84,366 | $12,700 | 15.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 86 | 86 | $26,918 | $9,930 | 36.9% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 20 | 23 | $32,315 | $9,882 | 30.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 582 | 963 | $53,928 | $8,951 | 16.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 50 | 60 | $16,620 | $7,756 | 46.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 113 | 117 | $19,576 | $6,127 | 31.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 45 | 45 | $12,105 | $4,555 | 37.6% |
| 93460 | Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 14 | 14 | $12,376 | $3,622 | 29.3% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 18 | 72 | $9,648 | $3,224 | 33.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 38 | 41 | $5,781 | $2,208 | 38.2% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Facility | 2023 | 42 | 101 | $7,171 | $2,200 | 30.7% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 31 | 31 | $8,089 | $1,730 | 21.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 15 | 16 | $3,248 | $1,480 | 45.6% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Office | 2023 | 136 | 136 | $6,800 | $1,457 | 21.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 141 | 195 | $1,365 | $1,338 | 98.0% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 26 | 26 | $6,058 | $1,197 | 19.8% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 54 | 55 | $3,025 | $869.76 | 28.8% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Office | 2023 | 13 | 22 | $2,860 | $593.67 | 20.8% |
| 93288 | Evaluation of single, dual, multiple lead or leadless pacemaker system | Office | 2023 | 14 | 15 | $1,575 | $533.17 | 33.9% |
About Dr. Michael Langiulli, MD
Dr. Michael Langiulli, MD is a Cardiovascular Disease healthcare provider based in Monroe, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1992765440.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Langiulli, MD has received a total of $54,994 in payments from pharmaceutical and medical device companies, with $734.64 received in 2024. These payments were reported across 355 transactions from 40 companies. The most common payment nature is "Royalty or License" ($46,257).
As a Medicare-enrolled provider, Langiulli has provided services to 11,912 Medicare beneficiaries, totaling 16,703 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 117 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Interventional Cardiology, Internal Medicine
- Location Monroe, LA
- Active Since 03/27/2006
- Last Updated 05/05/2017
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1992765440
Products in Payments
- Architect system (Device) $46,257
- Asahi Fielder coronary guide wire (Device) $2,684
- ENTRESTO (Drug) $893.30
- LifeVest (Device) $361.41
- ELIQUIS (Drug) $292.57
- PRALUENT (Drug) $284.42
- XARELTO (Drug) $282.90
- MULTAQ (Drug) $239.00
- VERQUVO (Drug) $204.75
- Xience Alpine cornary stent system (Device) $203.71
- OPSUMIT MACITENTAN (Drug) $150.49
- LEQVIO (Drug) $140.40
- Repatha (Biological) $134.60
- JARDIANCE (Drug) $128.56
- Coronary Orbital Atherectomy System (Device) $126.36
- IGT D Peripheral (Device) $120.61
- Optitorque (Device) $118.00
- AVVIGO Guidance System (Device) $105.85
- DIAMONDBACK CORONARY (Device) $101.48
- NEXLETOL (Drug) $91.42
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Monroe
Imran Chaudry, Md, MD
Cardiovascular Disease — Payments: $187,331
Cardiovascular Disease $187,331
Mark Napoli, M. D, M. D
Cardiovascular Disease — Payments: $147,448
Cardiovascular Disease $147,448
Mazen Iqbal, Md, MD
Cardiovascular Disease — Payments: $69,555
Cardiovascular Disease $69,555
Dr. Pratik Patel, Md, MD
Cardiovascular Disease — Payments: $42,553
Cardiovascular Disease $42,553
Dr. Gregory Sampognaro, M.d, M.D
Cardiovascular Disease — Payments: $19,585
Cardiovascular Disease $19,585
Dr. James Roberts, Md, MD
Cardiovascular Disease — Payments: $14,876
Cardiovascular Disease $14,876